Viewing Study NCT00147160


Ignite Creation Date: 2025-12-25 @ 2:10 AM
Ignite Modification Date: 2025-12-26 @ 6:25 PM
Study NCT ID: NCT00147160
Status: COMPLETED
Last Update Posted: 2012-04-11
First Post: 2005-09-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Cisplatin + Temozolomide in Malignant Glial Tumours in Children and Adolescents
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module